Clinical Trial

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-12-11; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2025-12-01
Trial Details
NCT Number NCT04670666
Lead Sponsor EMS
Conditions Type 2 Diabetes Mellitus
Enrollment 270 participants
Start Date 2024-11-18
Primary Completion 2026-07 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-08